ARS-1620 |
Covalent Inhibitor of KRAS (Mutant:G12C)
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| KRAS (Mutant:G12C) |
|
|
Covalent Inhibitor
0.3 - 3.0 uM
Selectivity
In Cell Selectivity Assessment
Selectivity Assessment Description:
Proteome and Transcriptome Profiling the Functional Selectivity of ARS-1620 for KRASG12C and Associa ...
Potency Cellular
In Vitro
KRAS
(Mutant:G12C)
Mode of Action: Covalent Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1016/j.cell.2018.01.006
In Vivo Validations
Mouse
Dose: 50 mg/Kg, 200 mg/Kg
Route of delivery:
Oral
Plasma half life:
2.5 h (Mouse), 3.5 h (Human)
DOI Reference: 10.1016/j.cell.2018.01.006
Negative Control Compounds
R-atropisomer
Chemical Information
| Molecular Formula | C21H17ClF2N4O2 |
| SMILEs | C=CC(=O)N1CCN(c2ncnc3c(F)c(-c4c(O)cccc4F)c(Cl)cc23)CC1 |
| InChI | InChI=1S/C21H17ClF2N4O2/c1-2-16(30)27-6-8-28(9-7-27)21-12-10-13(22)17(19(24)20(12)25-11-26-21)18-14(23)4-3-5-15(18)29/h2-5,10-11,29H,1,6-9H2 |
| Molecular weight | 430.10 Da |
| AlogP | 3.768600000000003 |
| HBond acceptors | 6 |
| HBond donors | 1 |
| Atoms | 47 |
References
Publications
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.